How much does Syncona typically invest?

Syncona states a typical cheque of €9M – €30M.

Which stages does Syncona invest in?

Syncona invests at Series A and Seed.

Where is Syncona based?

Syncona is headquartered in London, United Kingdom.

Investor directory

Syncona

VC fundLondon, United Kingdomsynconaltd.com LinkedIn

Syncona invests in life science companies across various therapeutic areas and stages of development.

What they invest in

Stages

Series A Seed

Sectors

Biotech & Pharma HealthTech Impact

Geographies

United Kingdom

The facts

Typical cheque: €9M – €30M
Headquarters: London, United Kingdom
Founded: 2012

Portfolio companies

Purespring Therapeutics

More portfolio companies

SwanBio TherapeuticsGyroscopeNightstaRxAutolus (NAS: AUTL)Achilles TherapeuticsALTx TherapeuticsOrbit BiomedicalRe-Aim TherapeuticsBACITAutolus TherapeuticsBeacon TherapeuticsSpur TherapeuticsiOncturaQuell TherapeuticsAnaveonMosaic TherapeuticsResolution TherapeuticsForcefield TherapeuticsOMass TherapeuticsKesmalea TherapeuticsYellowstone BiosciencesSlingshot TherapeuticsGyroscope TherapeuticsBlue Earth

and 5 more

Questions founders ask

How much does Syncona typically invest?: Syncona states a typical cheque of €9M – €30M.
Which stages does Syncona invest in?: Syncona invests at Series A and Seed.
Where is Syncona based?: Syncona is headquartered in London, United Kingdom.

Does Syncona fit your round?

In 30 minutes you'll know which funds matter for your round.

Request access

Are you Syncona? Tell us what to correct and we will update it — or ask us to remove the entry.